Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.

Pittock RR, Aakre JA, Castillo AM, Ramanan VK, Kremers WK, Jack CR Jr, Vemuri P, Lowe VJ, Knopman DS, Petersen RC, Graff-Radford J, Vassilaki M

Open source

DOI
10.1212/wnl.0000000000207770
Published
2023 Nov 7
Container
Neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000207770,
  title = {Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.},
  author = {Pittock RR and Aakre JA and Castillo AM and Ramanan VK and Kremers WK and Jack CR Jr and Vemuri P and Lowe VJ and Knopman DS and Petersen RC and Graff-Radford J and Vassilaki M},
  year = {2023},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000207770},
  url = {https://doi.org/10.1212/wnl.0000000000207770}
}

RIS

TY  - JOUR
TI  - Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
AU  - Pittock RR
AU  - Aakre JA
AU  - Castillo AM
AU  - Ramanan VK
AU  - Kremers WK
AU  - Jack CR Jr
AU  - Vemuri P
AU  - Lowe VJ
AU  - Knopman DS
AU  - Petersen RC
AU  - Graff-Radford J
AU  - Vassilaki M
PY  - 2023
JO  - Neurology
DO  - 10.1212/wnl.0000000000207770
UR  - https://doi.org/10.1212/wnl.0000000000207770
ER  - 

APA

RR, P., JA, A., AM, C., VK, R., WK, K., Jr, J. C., P, V., VJ, L., DS, K., RC, P., J, G., & M, V. (2023). Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.. Neurology. https://doi.org/10.1212/wnl.0000000000207770

Source records